RecruitingNCT05751408

Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis

Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis in Adult Patients With Neurological Disorders


Sponsor

Roessingh Research and Development

Enrollment

40 participants

Start Date

Jan 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

A standard clinical gait analysis consists of observing walking with video (2D) or advanced equipment (VICON 3D). This 3D method provides detailed information about the gait pattern, but is time-consuming in implementation and data analysis. There are commercial 3D systems on the market that are used in healthy individuals and in sports. These so-called Inertial Measurement Units (IMUs) may also be suitable for use in the clinic. In this research protocol, the aim is to test the usability of commercial sensors and technically compare them with standard clinical 3D gait analysis in adult patients with a neurological disorder.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called gait analysis using 3D (Vicon) and IMU (Movella) for people with gait analysis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREgait analysis using 3D (Vicon) and IMU (Movella)

Subjects are measured using Vicon 3D analysis, combined with IMU-sensors


Locations(1)

Roessingh Research and Development

Enschede, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05751408


Related Trials